Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ALRN-6924 |
Trade Name | |
Synonyms | CS-0044703 |
Drug Descriptions |
ALRN-6924 (CS-0044703) binds to MDM2 and MDM4 (MDMX) and prevents their interaction with p53, resulting in restoration of p53 activity and potentially leading to increased tumor cell death (PMID: 29643228, PMID: 30253242). |
DrugClasses | MDM2 Inhibitor 23 MDM4 inhibitor 8 |
CAS Registry Number | NA |
NCIT ID | C118669 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ALRN-6924 | ALRN-6924 | 9 | 3 |
ALRN-6924 + Carboplatin + Pemetrexed Disodium | ALRN-6924 Carboplatin Pemetrexed Disodium | 0 | 1 |
ALRN-6924 + Cyclophosphamide + Docetaxel + Doxorubicin | ALRN-6924 Cyclophosphamide Docetaxel Doxorubicin | 0 | 1 |
ALRN-6924 + Cytarabine | ALRN-6924 Cytarabine | 0 | 2 |
ALRN-6924 + Paclitaxel | ALRN-6924 Paclitaxel | 0 | 1 |
ALRN-6924 + Topotecan | ALRN-6924 Topotecan | 0 | 1 |